I cannot make any recommendations as to treatment without examining you. That is a decision that must be made in conjunction with your urologist and oncologist.
However, I can give you information about the long term problems with seeds (brachytherapy). The following is taken from UptoDate, and comments on some of the
factorsFactor ix complex affecting the decision:
"Men who undergo brachytherapy may experience acute inflammation and swelling of the prostate gland, which can lead to retention of urine. Thus, men with large or enlarged prostate glands are not good candidates for this treatment. In addition, damage to nearby tissue can cause bowel urgency and frequency, rectal bleeding, and the development of rectal ulcers; these symptoms tend to improve over time.
The risk of urinary incontinence and sexual impotence may be less with brachytherapy than with EBRT, but health-related quality of life is similar following brachytherapy, EBRT, and surgery.
A rare complication of prostate brachytherapy is migration of the seeds to the lung. This usually does not cause symptoms, and the clinical significance is unclear.
For men with early stage prostate cancer, current practice suggests that surgery and radiation therapy produce similar outcomes except for men with aggressive tumors, who may do better with surgery. The "cost" of better tumor control with surgery is a higher frequency of urinary and sexual side effects. Watchful waiting is considered appropriate only for older men with a small tumors, a low Gleason score, and a life expectancy of 15 years or less.
Often, the decision between radiation and surgery is a matter of patient preference. Younger men may be better served by surgery because they are more likely to survive beyond ten years. Older men may prefer radiation therapy to avoid the risks associated with anesthesia and the recovery period associated with major surgery. Although brachytherapy offers some advantages over external beam radiotherapy, there is not enough long-term follow-up data to recommend this approach as a first option, especially in younger men with long life expectancies." (1)
Followup with your personal physician is essential.
This answer is not intended as and does not substitute for medical advice - the information presented is for patient education only. Please see your personal physician for further evaluation of your individual case.
Thanks,
Kevin, M.D.
Bibliography:
1) Klein. Patient information: Treatment for early prostate cancer. UptoDate, 2003.